Top compounds associated with response to TPO


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CCLE pan-cancer AAC 0.031 0.5
mRNA PD-0325901 CCLE pan-cancer AAC 0.022 0.6
mRNA lapatinib CCLE pan-cancer AAC 0.02 0.7
mRNA paclitaxel CCLE pan-cancer AAC 0.018 0.7
mRNA L-685458 CCLE pan-cancer AAC 0.013 0.8
mRNA Nilotinib CCLE pan-cancer AAC -0.013 0.8
mRNA 17-AAG CCLE pan-cancer AAC 0.011 0.8
mRNA Sorafenib CCLE pan-cancer AAC -0.0099 0.8
mRNA Crizotinib CCLE pan-cancer AAC -0.0088 0.8
mRNA PD-0332991 CCLE pan-cancer AAC 0.0085 0.9
Download CSV